CHF2.62
0.77% day before yesterday
SIX Swiss Exchange, Dec 27, 09:47 am CET
ISIN
IL0010855885
Symbol
SHLTN

SHL Telemedicine Stock price

CHF2.62
+0.13 5.22% 1M
-2.13 44.84% 6M
-4.33 62.30% YTD
-4.13 61.19% 1Y
-16.38 86.21% 3Y
-3.18 54.83% 5Y
-6.83 72.28% 10Y
SIX Swiss Exchange, Closing price Fri, Dec 27 2024
+0.02 0.77%
ISIN
IL0010855885
Symbol
SHLTN

Key metrics

Market capitalization CHF42.95m
Enterprise Value CHF43.43m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.87
P/S ratio (TTM) P/S ratio 0.87
P/B ratio (TTM) P/B ratio 0.71
Revenue growth (TTM) Revenue growth -7.34%
Revenue (TTM) Revenue CHF49.65m
EBIT (operating result TTM) EBIT CHF-5.68m
Free Cash Flow (TTM) Free Cash Flow CHF-10.00k
EPS (TTM) EPS CHF-0.48
P/E forward negative
P/S forward 1.04
EV/Sales forward 0.99
Show more

Is SHL Telemedicine a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

SHL Telemedicine Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast SHL Telemedicine:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast SHL Telemedicine:

Buy
100%

Financial data from SHL Telemedicine

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
50 50
7% 7%
100%
- Direct Costs 27 27
10% 10%
54%
23 23
4% 4%
46%
- Selling and Administrative Expenses 17 17
17% 17%
33%
- Research and Development Expense 4.85 4.85
16% 16%
10%
1.33 1.33
383% 383%
3%
- Depreciation and Amortization 7.01 7.01
3% 3%
14%
EBIT (Operating Income) EBIT -5.68 -5.68
22% 22%
-11%
Net Profit -7.84 -7.84
270% 270%
-16%

In millions CHF.

Don't miss a Thing! We will send you all news about SHL Telemedicine directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

SHL Telemedicine Ltd. engages in the development and market of advanced personal telemedicine solutions, which focuses on cardiovascular and related diseases. Its products and solutions include congestive heart failure, chronic obstructive pulmonary disease and cardiac monitoring services. The company was founded by Yoram Alroy and Elon Shalev in 1987 and is headquartered in Tel Aviv, Israel.

Head office Israel
CEO David Arnon
Employees 583
Founded 1987
Website www.shl-telemedicine.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today